Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Seok Yun Kang"'
Autor:
Liang Huang, Da Pang, Hongjian Yang, Wei Li, Shusen Wang, Shude Cui, Ning Liao, Yongsheng Wang, Chuan Wang, Yuan-Ching Chang, Hwei-Chung Wang, Seok Yun Kang, Jae Hong Seo, Kunwei Shen, Suphawat Laohawiriyakamol, Zefei Jiang, Haiyan Wang, François Lamour, Grace Song, Michelle Curran, Chunzhe Duan, Sanne Lysbet de Haas, Eleonora Restuccia, Zhimin Shao
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract The randomized, multicenter, double-blind, placebo-controlled, phase III PEONY trial (NCT02586025) demonstrated significantly improved total pathologic complete response (primary endpoint) with dual HER2 blockade in HER2-positive early/local
Externí odkaz:
https://doaj.org/article/483aaf8ea22445929229f4f4bb8b8966
Autor:
Tae-Hwan Kim, Jin-Hyuk Choi, Mi Sun Ahn, Hyun Woo Lee, Seok Yun Kang, Yong Won Choi, Young Wha Koh, Seung-Soo Sheen
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Both first and second-generation EGFR-TKIs are recommended in advanced NSCLC with common EGFR mutations. However, there are few data on the difference in efficacy of EGFR-TKIs based on the type of EGFR mutation and agents. Methods
Externí odkaz:
https://doaj.org/article/1e058ad9026f43c9ab335dd0de4e72b5
Autor:
Tae-Hwan Kim, Mi Sun Ahn, Yong Won Choi, Seok Yun Kang, Jin-Hyuk Choi, Hyun Woo Lee, Minae Park, Hasung Kim
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background One-year S-1 or six-month capecitabine/oxaliplatin (CAPOX) has been the standard adjuvant chemotherapy for gastric cancer (GC). We investigated outcomes according to the cycles of adjuvant chemotherapy, using data from the Korean
Externí odkaz:
https://doaj.org/article/4705b50223f041dba6c948f47c57b334
Autor:
Hundo Cho, Jin-Hyuk Choi, Seok Yun Kang, Hyun Woo Lee, Yong Won Choi, Tae-Hwan Kim, Mi Sun Ahn, Chul-Ho Kim, Yoo Seob Shin, Jeon Yeob Jang, Young-Taek Oh, Jaesung Heo, Seung Soo Sheen
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 3, Pp 653-659 (2022)
Background/Aims The study investigated the incidence of thromboembolic events (TEE) in head and neck (H&N) cancer patients who received concurrent chemoradiotherapy (CCRT) with cisplatin, and analyzed the factors affecting TEE occurrence Methods Two
Externí odkaz:
https://doaj.org/article/ecaca389f3d04368b9914e17fec0868d
Autor:
Tae-Hwan Kim, Yong Won Choi, Hyun Woo Lee, Seok Yun Kang, Heejun Son, Jin-Hyuk Choi, Mi Sun Ahn, Seung-Soo Sheen
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract Thromboembolic events (TEEs) are common in cancer patients, with increased risk of TEE by chemotherapy in patients with lung cancer. However, TEEs in patients with non-small cell lung cancer (NSCLC) who received adjuvant chemotherapy have ra
Externí odkaz:
https://doaj.org/article/7c7cc83de76948b18cf41fb613170a36
Autor:
Soohyeon Lee, Kyunghee Park, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Hee Kyung Ahn, Woong-Yang Park, Seock-Ah Im, Yeon Hee Park
Publikováno v:
Breast, Vol 62, Iss , Pp 52-60 (2022)
Background: Palbociclib plus endocrine therapy (ET) demonstrated significant progression-free survival (PFS) benefit in Young Pearl, a randomized phase ll trial comparing palbociclib + ET versus capecitabine in premenopausal women with hormone recept
Externí odkaz:
https://doaj.org/article/30a55aa347d34ca5a2ac5cb61a35e935
Autor:
Jin-Hyuk Choi, Yong Won Choi, Hyun Woo Lee, Seok Yun Kang, Geum Sook Jeong, Mi Sun Ahn, Young-Taek Oh, O kyu Noh, Se-Hyuk Kim, Tae Hoon Roh, Seung Soo Sheen
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 2, Pp 434-443 (2022)
Background/Aims The optimal treatment (Tx) for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) patients with brain metastasis (BM) remains to be determined. Methods A retrospective review was conducted on 77 NSCLC pa
Externí odkaz:
https://doaj.org/article/0239a5d197c94c45a34bfb636467c0b4
Autor:
Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, Tae-Yong Kim, Seok Yun Kang, Joohyuk Sohn, Yaewon Yang, Kyong Hwa Park, Yong Wha Moon, Seungtaek Lim, Myoung Joo Kang, Koung Eun Yoon, Hyun Ju Cho, Keun Seok Lee
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Standard intravenous (IV) paclitaxel is associated with hypersensitivity/toxicity. Alternative IV formulations have improved tolerability but still require frequent hospital visits and IV infusion. DHP107 is a novel oral formulation of pa
Externí odkaz:
https://doaj.org/article/d67c1aea2ed64ac8bad679b39788b980
Autor:
Jin-Hyuk Choi, Yong Won Choi, Seok Yun Kang, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Joon Seong Park, Mi Sun Ahn, Seung Soo Sheen
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Although combination chemotherapy (CC) is generally recommended in recurrent or primary metastatic gastric cancer (RPMGC), the results of randomized trials are conflicting. Methods A retrospective review was conducted on 687 RPMGC
Externí odkaz:
https://doaj.org/article/cd68838292f94f4797ed4a90c81c76ee
Autor:
Hyun Ee Yim, Jang-Hee Kim, Mi Sun Ahn, Yongsik Jung, Jin Roh, So Hyun Park, Tae-Gyu Kim, Jin-Hyuk Choi, Seok Yun Kang
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Pure mucinous breast carcinoma (PMBC) is characterized by clusters of tumor cells floating in abundant extracellular mucin and can be classified into paucicellular (Type A) and hypercellular (Type B) subtypes. However, the clinicopathological and gen
Externí odkaz:
https://doaj.org/article/6bc997badad943f29b70d2968a08f433